Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Portage Biotech Inc.
Fiscal year is April-March. All values USD millions. 2013 2014 5-year trend
Sales/Revenue - - - 0 0
Cost of Goods Sold (COGS) incl. D&A - - - - 40,512
COGS excluding D&A - - - - 39,348
Depreciation & Amortization Expense - - - - 1,164
Depreciation - - - 0 1,164
Amortization of Intangibles - - - 0 -
Gross Income - - - - (40,512)
2013 2014 5-year trend
SG&A Expense - - - 29,486 2.75M
Research & Development - - - 26,976 1.14M
Other SG&A - - - 2,510 1.62M
Other Operating Expense - - - 0 0
Unusual Expense - - - 0 3.84M
EBIT after Unusual Expense - - - 0 (3.84M)
Non Operating Income/Expense - - - 0 5,565
Non-Operating Interest Income - - - - -
Equity in Affiliates (Pretax) - - - 0 0
Interest Expense - - - 0 0
Gross Interest Expense - - - 0 0
Interest Capitalized - - - 0 0
Pretax Income - - - (29,486) (6.63M)
Income Tax - - - 0 0
Income Tax - Current Domestic - - - 0 0
Income Tax - Current Foreign - - - 0 0
Income Tax - Deferred Domestic - - - 0 0
Income Tax - Deferred Foreign - - - 0 0
Income Tax Credits - - - 0 0
Equity in Affiliates - - - 0 0
Other After Tax Income (Expense) - - - 0 0
Consolidated Net Income - - - (29,486) (6.63M)
Minority Interest Expense - - - 0 (321,683)
Net Income - - - (29,486) (6.3M)
Extraordinaries & Discontinued Operations - - - 0 0
Extra Items & Gain/Loss Sale Of Assets - - - 0 0
Cumulative Effect - Accounting Chg - - - 0 0
Discontinued Operations - - - 0 0
Net Income After Extraordinaries - - - (29,486) (6.3M)
Preferred Dividends - - - 0 0
Net Income Available to Common - - - (29,486) (6.3M)
EPS (Basic) - - - () (0.04)
Basic Shares Outstanding - - - 81.76M 161.98M
EPS (Diluted) - - - () (0.04)
Diluted Shares Outstanding - - - 81.76M 161.98M
EBITDA - - - - (2.79M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.